Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
119,021 Orion Corporation A shares converted into B shares | ||||||
By: GlobeNewswire - 07 Feb 2024 | Back to overview list |
|||||
ORION CORPORATION 119,021 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 119,021 A shares have been converted into 119,021 B shares. The conversion has been entered into the Trade Register on 7 February 2024. The total number of shares in Orion Corporation is 141,134,278 which, after the conversion, consists of 33,232,361 A shares and 107,901,917 B shares. The number of votes of the company's shares is after the conversion 772,549,137. Orion Corporation
Publisher: Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and self-care products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2022 amounted to EUR 1,341 million and the company had about 3,500 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki. |
||||||
|
||||||
Copyright 2024 GlobeNewswire | Back to overview list |